Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma
The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Microglia activation and release of pro‐inflammatory cytokines have been closely linked to glaucoma. However, the mechanisms that initiate these pathways remain unclear. Here, we investigated the role of a pro‐inflammatory cytokine––osteopontin (OPN), in retinal microglia activation process along with the underlying mechanisms in glaucoma. A rat chronic ocular hypertension (COH) model was established presenting an increase in retinal OPN level and activation of microglia. Primary microglia cells were isolated and cultured under a pressure culture system showing heightened expressions of microglia‐derived OPN with changes in inflammatory factors (TNF‐α, IL‐1β, and IL‐6). OPN and OPN neutralizing antibody (Anti‐OPN) interventions were both applied systems for comparison, and cross‐referenced with OPN knockdown in vitro. JAK/STAT, NF‐κB, ERK1/2, and p38 MAPK, recognized as the primary signaling pathways related to microglia activation, were then screened on whether they can facilitate OPN to act on microglia and their impact on specific inhibitors. Thereafter, retrograde labeling of retinal ganglion cells (RGCs) and flash visual evoked potentials (F‐VEP) were used to investigate neuron protection in context of each blockade. Results suggest that OPN is able to enhance the proliferation and activation of retinal microglia in experimental glaucoma which may play a role in the glaucomatous optic neuropathy, and contribute to the eventual RGCs loss and vision function impairment. Such effect may be mediated through the regulation of p38 MAPK signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pharmacological inhibition of the p38 pathway reduced the pro-inflammatory activation of retinal microglia [ 126 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [126]
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
The functional diversity of retinal ganglion cells in the mouse
Baden, T., Berens, P., Franke, K., Román Rosón, M., Bethge, M., & Euler, T. (2016) · Nature · doi:10.1038/nature16468 · Cited by 999
Kerrigan, L. A., Quigley, H. A., Pease, M. E., Kerrigan, D., & Mitchell, R. S. (2000) · PubMed · Cited by 996
The Types of Retinal Ganglion Cells: Current Status and Implications for Neuronal Classification
Sanes, J. R., & Masland, R. H. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-034120 · Cited by 789
Histone deacetylases, transcriptional control, and cancer
Cress, W. D., & Seto, E. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200007)184:1<1::aid-jcp1>3.0.co;2-7 · Cited by 621
Norden, D. M., Trojanowski, P. J., Villanueva, E., Navarro, E., & Godbout, J. P. (2016) · Glia · doi:10.1002/glia.22930 · Cited by 590
Chronic human glaucoma causing selectively greater loss of large optic nerve fibers
Quigley, H. A., Dunkelberger, G. R., & Green, W. R. (1988) · Ophthalmology · doi:10.1016/s0161-6420(88)33176-3 · Cited by 563
Early microglia activation in a mouse model of chronic glaucoma
Bosco, A., Steele, M. R., & Vetter, M. L. (2011) · Journal of Comparative Neurology · doi:10.1002/cne.22516 · Cited by 350
Zohar, R., Suzuki, N., Suzuki, K., Arora, P., Glogauer, M., McCulloch, C. A. G., & Sodek, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200007)184:1<118::aid-jcp13>3.0.co;2-y · Cited by 276
Della Santina, L., Inman, D. M., Lupien, C. B., Horner, P. J., & Wong, R. O. L. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.5461-12.2013 · Cited by 259
Cited by
The Role of Osteopontin in Microglia Biology: Current Concepts and Future Perspectives
Rosmus, D.-D., Lange, C., Ludwig, F., Ajami, B., & Wieghofer, P. (2022) · Biomedicines · doi:10.3390/biomedicines10040840 · Cited by 67
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“Pharmacological inhibition of the p38 pathway reduced the pro-inflammatory activation of retinal microglia [126].”
BackgroundWang, C., An, Y., Xia, Z., Zhou, X., Li, H., Song, S., Ding, L., & Xia, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.986131 · Cited by 41
Palazzo, I., Kelly, L. E., Koenig, L., & Fischer, A. J. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114233 · Cited by 41
Wang, X., Sun, L. D., Han, X., Li, Z., Xing, Y., Chen, X., Xi, R., Sun, Y., Wang, G., & Zhao, P. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5504 · Cited by 33
Lee, S.-H., Park, Y. S., Paik, S.-S., & Kim, I. (2021) · Cells · doi:10.3390/cells10081972 · Cited by 18
Yu, H., Shen, B., Han, R., Zhang, Y., Xu, S., Zhang, Y., Guo, Y., Huang, P., Huang, S., & Zhong, Y. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00343-4 · Cited by 16
Self-citationOsteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina
Someya, H., Ito, M., Nishio, Y., Sato, T., Harimoto, K., & Takeuchi, M. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109094 · Cited by 15
Zhong, H., Yu, H., Chen, B., Guo, L., Xu, X. Y., Jiang, M., Zhong, Y., Qi, J., & Huang, P. (2021) · BioMed Research International · doi:10.1155/2021/4356949 · Cited by 13
Self-citationLi, T., Xin, D., Ke, H., Chu, X., Zhao, Y., Yue, S., Liu, D.-X., & Wang, Z. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00794-2 · Cited by 13
New strategies for neuro protection in glaucoma
Xuejiao, Y., & Junwei, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.983195 · Cited by 11
Molecular signaling from microglia impacts macroglia autophagy and neurons survival in glaucoma
Yu, H., Zhong, H., Sun, J. Y., Li, N., Chen, J., Shen, B., Huang, P. C., Shen, X. P., Huang, S., & Zhong, Y. (2023) · iScience · doi:10.1016/j.isci.2023.106839 · Cited by 10
Self-citationTruncation mutations in MYRF underlie primary angle closure glaucoma
Ouyang, J., Sun, W., Shen, H., Liu, X., Wu, Y., Jiang, H., Li, X., Wang, Y., Jiang, Y., Li, S., et al. (2022) · Human Genetics · doi:10.1007/s00439-022-02487-0 · Cited by 9
Self-citationOsteopontin is a biomarker for early autoimmune uveoretinitis
Shin, T., Kim, J., Ahn, M., Choi, Y., Chun, J., Jung, K., Tanaka, A., & Matsuda, H. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.330614 · Cited by 9
Yu, H., Zhang, Y., Zhong, H., Zhang, Y., He, S., Zhang, Y., Wang, Y., Chen, J., Guo, Y., Shen, X., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124054 · Cited by 8
Self-citationSu, A.-L., Zhao, S., Hong-Na, Z. H. U., Ying, Q. I. A. O., & Zhang, T. (2024) · Biomedical Research · doi:10.2220/biomedres.45.13 · Cited by 8
Liu, W., Wang, Y., Liu, C., Shi, B., Xiong, X., Chen, S., Huang, Q.-Q., Wang, L., Zeng, G., & Huang, Q. (2025) · The FASEB Journal · doi:10.1096/fj.202403104rr · Cited by 8
Therapeutic potential of curcumin in ophthalmic diseases: mechanisms and clinical applications
Wang, K., Tian, T., Chen, Z., He, X., Xiang, Y., Zuo, G., & Cheng, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07458-3 · Cited by 7
Kalinin, S., Boullerne, A. I., & Feinstein, D. L. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577810 · Cited by 7
The immune duality of osteopontin and its therapeutic implications for kidney transplantation
Leung, J., Qu, L., Ye, Q., & Zhong, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1520777 · Cited by 6
Balikoglu-Yilmaz, M., Kumcu, N. D., Daldal, H., Imre, S. S., Aydın, E., Özgül, S., & Köse, T. (2021) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-021-05182-4 · Cited by 6
Mechanobiology of Adipose Tissue Remodeling
Frosti, C. L., Connelly, S. P., & Layne, M. D. (2025) · Tissue Engineering Part A · doi:10.1177/19373341251405218 · Cited by 6
Targeting circular RNA-Glra2 alleviates retinal neurodegeneration induced by ocular hypertension
Wang, T., Li, S., Li, X., Li, C., Wang, F., & Jiang, Q. (2023) · Aging · doi:10.18632/aging.205108 · Cited by 5
The causal effect of glaucoma and diabetic retinopathy: a Mendelian randomization study
Chen, S., Lin, M., & Yu, H. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01652-5 · Cited by 4
Self-citationLiu, J., Luo, S., Hu, Y., & Peng, X. (2023) · Quality Assurance and Safety of Crops & Foods · doi:10.15586/qas.v15i1.1235 · Cited by 3
Salkar, A., Palanivel, V., Basavarajappa, D. K., Heng, B., Schulz, A. M., Gupta, V. K., Graham, S. L., Mirzaei, M., & You, Y. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-01905 · Cited by 2
Ji, W., Sun, Z., Yang, Y., Hu, M., Zhang, Q., Fu, J., Chen, J., Huang, Y., & Cheng, Y.-Y. (2023) · Journal of Burn Care & Research · doi:10.1093/jbcr/irad036 · Cited by 2
Self-citationLin, Z., Li, R., Wang, H., & Mao, K. (2023) · Discovery Medicine · doi:10.24976/discov.med.202335178.74 · Cited by 2
Yu, H., Xu, T., Feng, Q., Wang, Y., Zou, J., & Ma, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1660294 · Cited by 1
Self-citationBastelica, P., Reboussin, É., Przegralek, L., Darche, M., Buffault, J., Goazigo, A. R.-L., Labbé, A., Parsadaniantz, S. M., & Baudouin, C. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119648 · Cited by 1
Neuroprotective Effects of the SIRT3/AMPK Axis in Experimental Glaucoma
Chen, F., Yu, Y., Cai, X., & Lu, X. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl46525
Feng, L., Chen, Y., Wang, C., Zhu, W., Zhang, C., Huang, Q., & Song, W. (2025) · PubMed Central · doi:10.11817/j.issn.1672-7347.2025.250416
Therapeutic potential of mesenchymal stem cells in ocular degenerative disorders
Xiang, Y., Zuo, G., He, X., Wang, K., Zhu, Y., & Cheng, S. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07878-9
Song, J., Zhang, X., Huang, P., Li, H., Liu, W., Wang, L., Wang, R., Ye, Z., Zhang, J., Zhang, Z., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04661-2
Self-citationFirth, W., Ďuďáková, Ľ., Dobrovolný, R., Honzík, T., Lišková, P., Albon, J., & Votruba, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.23.740295
Neuron-derived SPP1 instructs microglia to limit degeneration
Li, S., & Jakobs, T. (2026) · Science Advances · doi:10.1126/sciadv.aee4940
Sun, Y., Xue, K., Wen, C., Ma, X., & Hu, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1932850
Metadata
- Authors
- Yu, H., Zhong, H., Li, N., Chen, K., Chen, J., Sun, J., Xu, L., Wang, J., Zhang, M., Liu, X., Deng, L., Huang, P., Huang, S., Shen, X., & Zhong, Y.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Shen, Xi
- Zhong, Yisheng
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2021-02-09
- Volume
- 35
- Issue
- 3
- Pages
- e21405-e21405
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W3126725218
- Cited by
- 33
- References
- 58
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 2 · 2023: 5 · 2022: 7 · 2021: 5
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (NO. 81870652, NO. 82070953, NO. 82000885)
- Health and Family Planning Commission of Sichuan Province (NO. 2020LP034, NO. 2018JP008)
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- osteopontin, retinal ganglion cell death, glaucoma, p38 MAPK signaling, chronic ocular hypertension, neuroinflammation, inflammatory cytokines, glaucomatous optic neuropathy, neuroprotection, JAK/STAT signaling, NF-κB, ERK1/2
- MeSH terms
- Animals, Disease Models, Animal, Evoked Potentials, Visual, Glaucoma, Male, Ocular Hypertension, Retina, Retinal Ganglion Cells, Tumor Necrosis Factor-alpha, Cytokines, Rats, Sprague-Dawley, Microglia, p38 Mitogen-Activated Protein Kinases, Rats, Osteopontin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.